FDA: Deliveries of scarce childhood cancer drug due to resume later in October, but shortages may continue for months

Peter Adamson of the Perelman School of Medicine authored a letter proposing a “call to action” to make sure childhood-cancer drug shortages don’t reoccur.

・ From Forbes